[HTML] nature.com

[HTML][HTML] Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease

DK Wilton, K Mastro, MD Heller, FW Gergits… - Nature medicine, 2023 - nature.com
Huntington's disease (HD) is a devastating monogenic neurodegenerative disease
characterized by early, selective pathology in the basal ganglia despite the ubiquitous …
被引用次数：25 相关文章

Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease.

DK Wilton, K Mastro, MD Heller, FW Gergits… - Nature …, 2023 - europepmc.org
Huntington's disease (HD) is a devastating monogenic neurodegenerative disease
characterized by early, selective pathology in the basal ganglia despite the ubiquitous …
[HTML] nih.gov

[HTML][HTML] Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease

DK Wilton, K Mastro, MD Heller, FW Gergits… - Nature …, 2023 - ncbi.nlm.nih.gov
Huntington's disease (HD) is a devastating monogenic neurodegenerative disease
characterized by early, selective pathology in the basal ganglia despite the ubiquitous …

Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease

DK Wilton, K Mastro, MD Heller… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
Huntington's disease (HD) is a devastating monogenic neurodegenerative disease
characterized by early, selective pathology in the basal ganglia despite the ubiquitous …

Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease.

DK Wilton, K Mastro, MD Heller, FW Gergits… - Nature …, 2023 - europepmc.org
Huntington's disease (HD) is a devastating monogenic neurodegenerative disease
characterized by early, selective pathology in the basal ganglia despite the ubiquitous …